scispace - formally typeset
X

Xuerong Wang

Researcher at Nanjing Medical University

Publications -  28
Citations -  1765

Xuerong Wang is an academic researcher from Nanjing Medical University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 14, co-authored 20 publications receiving 1637 citations. Previous affiliations of Xuerong Wang include Emory University.

Papers
More filters
Journal ArticleDOI

Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition.

TL;DR: This study provides a mechanistic basis for enhancing mTOR-targeted cancer therapy by combining an mTOR inhibitor with a PI3K or Akt inhibitor and shows that rapamycin combined with LY294002 exhibited enhanced inhibitory effects on the growth and colony formation of cancer cells.
Journal ArticleDOI

Enhancing Mammalian Target of Rapamycin (mTOR)–Targeted Cancer Therapy by Preventing mTOR/Raptor Inhibition-Initiated, mTOR/Rictor-Independent Akt Activation

TL;DR: It is concluded that inhibition of the mTOR/raptor complex initiates Akt activation independent of m TOR/rictor, and the sustained Aktactivation during mTOR inhibition will counteract the anticancer efficacy of themTOR inhibitors.
Journal ArticleDOI

Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.

TL;DR: The results indicate that mTOR inhibitor-induced eIF4E phosphorylation is secondary to mTOR/raptor inhibition and independent of p70S6K, and suggest an effective therapeutic strategy for enhancing mTOR-targeted cancer therapy by cotargeting mTOR signaling and Mnk/eIF4e phosphorylated.
Journal ArticleDOI

Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy.

TL;DR: It is concluded that perifosine inhibits mTOR signaling and induces autophagy, highlighting a novel mechanism accounting for the anticancer activity of perifOSine and a potential strategy to enhance the anticancers efficacy of perIFosine by preventing autophagic.
Journal ArticleDOI

The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathway

TL;DR: It is indicated that activation of the extrinsic apoptotic pathway plays a critical role in perifosine-induced apoptosis, thus warranting future in vivo and clinical evaluation of per ifosine in combination with TRAIL in the treatment of NSCLC.